Dear BSBMTCT member,
Commissioners’ report 2022 The 13th Commissioners report and centre reports have now been completed and sent to all paid members. Thank you to all members that have paid and a special thanks to Julia Lee and Rachel Pearce for completing yet another major annual exercise – something that adds immense distinction (compared with many other specialities) of our BMT and cellular therapy community in delivering governance, quality improvement and duty to patient care through national and centre reports. If you have not received your reports, please contact Julia Lee via email, Julia.firstname.lastname@example.org if may be that we are still waiting for confirmation of payment.
Please save the dates for the upcoming BSBMTCT events :
The next joint meeting of IMPACT and BSBMTCT CTSC is being held in Birmingham on Thursday October 20th. This will be held at the The Edgbaston Park Hotel and Conference Centre. To register for the meeting please complete the form via this link https://forms.office.com/r/rCCsnSvvnG (Deadline to register is midnight Friday 30th September)
The BSBMTCT Education Day – Tuesday 1st November 2022, which will also be a Hybrid Event at Cavendish Conference Centre, 22 Duchess Mews, London W1G 9DT – Please register at: https://collaborativeconferences.co.uk/bsbb-home/
The BSBMTCT Scientific Day 2023 to be held on Wednesday 17 May 2023, hopefully as an in-person meeting. Matt Collin, as our Scientific Secretary, is already on the case!
Another date is the BSBMTCT Scientific showcase for advanced cell therapy subcommittee 2023, which had it’s first debut this Summer and was highly successful. Next year the provisional date for it to be held on Wednesday 21st June 2023 – to be confirmed.
Ruxolitinib ‘campaign’ – we are lobbying with Anthony Nolan and others to restore funded access to Ruxolitinib for graft-versus-host-disease – hopefully we will be able to regain the easy access supported during the pandemic to this valuable, evidence-based drug. Please see the BSBMTCT Position Statement on our website on this issue.
We will be sending out a survey soon to assess and promote Equality, Diversity and Inclusion (EDI) within BSBMTCT. Please complete it – it will be invaluable to the future of our Society, as well as meeting various requirements as a professional and charitable organisation.
Finally, we will be putting out notice of some vacancies in the BSBMTCT Executive in the next few months, including President Elect and Sub-Committee chairs. If you feel that you would like to contribute to BSBMTCT as a formal officer – and can dedicate the necessary time and commitment to deliver responsibilities and serve our BMT and cellular therapy community well – then please consider. Precise details will follow in due course.
Our very best wishes
John Snowden, Kim Orchard, Fiona Dignan, Deborah Richardson, Eduardo Olavarria, & Julia Lee